The impact of chemotherapy dose density and dose intensity on breast cancer outcome: what have we learned?
暂无分享,去创建一个
[1] D A Berry,et al. Dose and dose intensity as determinants of outcome in the adjuvant treatment of breast cancer. The Cancer and Leukemia Group B. , 1998, Journal of the National Cancer Institute.
[2] G. Bonadonna,et al. Karnofsky memorial lecture. Conceptual and practical advances in the management of breast cancer. , 1989, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[3] L. Norton,et al. Dose and dose intensity of adjuvant chemotherapy for stage II, node-positive breast carcinoma. , 1994, The New England journal of medicine.
[4] D A Berry,et al. erbB-2, p53, and efficacy of adjuvant therapy in lymph node-positive breast cancer. , 1998, Journal of the National Cancer Institute.
[5] C. Hudis,et al. Sequential adjuvant therapy: the Memorial Sloan-Kettering Cancer Center experience. , 1996, Seminars in oncology.
[6] M. Levine,et al. Analysis of dose intensity for chemotherapy in early (stage II) and advanced breast cancer. , 1986, NCI monographs : a publication of the National Cancer Institute.
[7] Stephen E. Jones,et al. Adjuvant Therapy of Cancer , 1990 .
[8] M. Levine,et al. Analysis of dose intensity for adjuvant chemotherapy trials in stage II breast cancer. , 1986, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[9] L. Biganzoli,et al. The bigger the better? ... or what we know and what we still need to learn about anthracycline dose per course, dose density and cumulative dose in the treatment of breast cancer. , 1997, Annals of oncology : official journal of the European Society for Medical Oncology.
[10] W. Hryniuk. More is better. , 1988, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[11] D. V. Von Hoff,et al. Use of in vitro dose response effects to select antineoplastics for high-dose or regional administration regimens. , 1986, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[12] W. Hryniuk,et al. The importance of dose intensity in chemotherapy of metastatic breast cancer. , 1984, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[13] D. Wickerham,et al. Increased intensification and total dose of cyclophosphamide in a doxorubicin-cyclophosphamide regimen for the treatment of primary breast cancer: findings from National Surgical Adjuvant Breast and Bowel Project B-22. , 1997, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[14] M. Venturini,et al. More on dose-intensity of anthracyclines in breast cancer. , 1998, Annals of oncology : official journal of the European Society for Medical Oncology.